Pay in 4 interest-free payments of $6.80 Learn more
Ships within 48 hours · Estimated delivery Oct 5 - Oct 10
Leung CM, de Haan P, Ronaldson-Bouchard K, Kim GA, Ko J, Rho HS, Chen Z, Habibovic P, Jeon NL, Takayama S, Shuler ML, Vunjak-Novakovic G, Frey O, Verpoorte E, Toh YC (2022) A guide to the organ-on-a-chip
monocytogenes strain secreting an antigen-adjuvant f FP (tLLO-HPV-16 E7) is now undergoing a Phase 3 clinical study to treat cervical cancer (NCT02853604i)
Singh, Centre for Bioinformatics, School of Biotechnology, for his assistance in the in silico study
The initial phase may consist of weekly injections for 8 to 10 weeks
US$ 21.18
US$ 24.36
US$ 28.04
US$ 23.74
